Eosinophils and COVID-19 prognosis

M. Ferchichi (Tunis, Tunisia), I. Khalfallah (Tunis, Tunisia), S. Louhaichi (Tunis, Tunisia), N. Boubaker (Tunis, Tunisia), J. Ammar (Tunis, Tunisia), B. Hamdi (Tunis, Tunisia), A. Hamzaoui (Tunis, Tunisia)

Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases
Session: Molecular pathology and cell biology of pulmonary diseases
Session type: E-poster
Number: 3621

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Ferchichi (Tunis, Tunisia), I. Khalfallah (Tunis, Tunisia), S. Louhaichi (Tunis, Tunisia), N. Boubaker (Tunis, Tunisia), J. Ammar (Tunis, Tunisia), B. Hamdi (Tunis, Tunisia), A. Hamzaoui (Tunis, Tunisia). Eosinophils and COVID-19 prognosis. 3621

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease
Source: Eur Respir Monogr 2022; 95: 219-237
Year: 2022


Subpopulations of cells from bronchoalveolar lavage can predict prognosis in sarcoidosis
Source: Eur Respir J, 55 (1) 1901450; 10.1183/13993003.01450-2019
Year: 2020



Phenotypes and prognosis
Source: International Congress 2019 – PG10 Severe asthma in adults: systematic assessment and biological treatment
Year: 2019


Eosinophils and eosinophilic immune dysfunction in health and disease
Source: Eur Respir Rev, 31 (163) 210150; 10.1183/16000617.0150-2021
Year: 2022



Monocytes and macrophages in chronic sarcoidosis pathology
Source: Eur Respir J, 54 (5) 1901626; 10.1183/13993003.01626-2019
Year: 2019



Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021


Neutrophils in CF lung disease
Source: Research Seminar 2008 - Host-pathogen interactions in the lung: implications for treatment of respiratory infections and inflammatory lung diseases
Year: 2008


Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease
Source: ERJ Open Res, 6 (4) 00481-2020; 10.1183/23120541.00481-2020
Year: 2020



Eosinophils as a predictor of mepolizumab treatment responses in COPD
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018




The role of bronchoalveolar lavage immunologic parameters in pulmonary sarcoidosis prognosis
Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Year: 2010


Markers of early disease and prognosis in COPD
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009


Monocytes and dendritic cells with hyperinflammatory profile in lungs of sarcoidosis patients
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018

Eosinophils are elevated in bronchial alveolar lavage before children develop clinical symptoms
Source: Annual Congress 2009 - New developments in preschool wheezing disorders and its genetic basis
Year: 2009

Sputum mast cells associate with clinical and inflammatory features of asthma
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020


Mast cells in lung disease: clinical implications
Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications
Year: 2019


Mast cells in lung disease
Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications
Year: 2019


Eosinophils in bronchial biopsy predict functional response to biological therapy in severe asthma
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021